| Value | ₹40.00 Cr |
|---|
NSE filing, NSE: JAGSNPHARM. Summary written from the filing by ALFA Finder's alert engine.
Jagsonpal Pharmaceuticals Ltd: key numbers
- Share price
- ₹216.21
- Market cap
- ₹1,426 Cr
- Revenue (annual)
- ₹287.2 Cr
- Net profit (annual)
- ₹43.08 Cr
- P/E (TTM)
- 31.4×Sector 41.3×
- Promoter holding
- 68.81%-0.24% QoQ
- FII holding
- 2.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jagsonpal Pharmaceuticals Ltd
All →Jagsonpal Pharmaceuticals Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹964 Mn (+29%, Aequitas consolidated); standalone revenue ₹814 Mn (+9.3%), EBITDA margin 22.7%, PAT ₹126 Mn flat. H1 standalone PAT +10.3%.
Jagsonpal Pharmaceuticals Results Update
Jagsonpal reported Q2 FY27 consolidated revenue up 29% to ₹964 Mn, with standalone revenue up 9.3%. Standalone H1 PAT grew 10.3% and cash stood at ₹1,347 Mn.
Jagsonpal Pharmaceuticals Q2 FY27 Results: Net Profit ₹12.6 Cr, Up 0.0% YoY
Jagsonpal Pharmaceuticals Ltd reported revenue from operations of ₹81.4 Cr (+9.3% YoY) and net profit of ₹12.6 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹12.6 Cr · +0.0% YoY
Jagsonpal Pharmaceuticals Board Meeting Date
Jagsonpal Pharmaceuticals Ltd will hold a Board Meeting on October 28, 2026, to consider and approve the company's unaudited financial results for the quarter ended September 30, 2026.
Jagsonpal Pharmaceuticals Other Announcement
Jagsonpal Pharmaceuticals Ltd filed its quarterly shareholding pattern statement in compliance with SEBI Regulation 31(1)(b).
Jagsonpal Pharmaceuticals Acquisition
Jagsonpal Pharmaceuticals has completed the acquisition of the Wellness Portfolio from Group Pharmaceuticals Limited, following the fulfilment of all conditions precedent in the agreement.
- From
- Group Pharmaceuticals Limited
Other annual general meeting announcements
All →SBI Life Insurance Company Annual General Meeting
SBI Life issued a postal ballot notice seeking member approval to appoint Mr. Nihar Jambusaria as Independent Director for three years. E-voting runs from November 4 to December 3, 2026.
- Execution
- September 22, 2026 to September 21, 2029
Shalby Annual General Meeting
Shalby Ltd seeks shareholder approval via postal ballot to appoint Shanay Vikram Shah and Tushar Shah as directors. E-voting runs November 5 to December 4, 2026.
Sayaji Hotels (Indore) Annual General Meeting
Sayaji Hotels seeks shareholder approval to appoint Azhar Yusuf Dhanani as non-executive director via postal ballot. E-voting runs until December 7, 2026.
InfoBeans Technologies Annual General Meeting
Infobeans Techno announced a postal ballot notice seeking shareholder approval to appoint Mr. Santosh Muchhal as an Independent Director for five years from October 17, 2026. Voting ends on December 3, 2026.
Atmastco Annual General Meeting
Atmastco Limited has issued notice of its 32nd Annual General Meeting on 25 November 2026. Agenda covers FY2025-26 financial statements, a director re-appointment and cost auditor remuneration.
Shreeji Global FMCG Annual General Meeting
Shreeji Global FMCG's EGM seeks approval for capital increase, bonus shares and preferential warrants. The warrants go to promoters and non-promoters, pending shareholder vote.